Literature DB >> 27162231

Response to Letter Regarding Article, "Comparative Effectiveness of Implantable Cardioverter Defibrillators for Primary Prevention in Women".

Emily P Zeitler1, Anne S Hellkamp2, Phillip J Schulte3, Gregg C Fonarow4, Adrian F Hernandez1, Eric D Peterson1, Gillian D Sanders2, Clyde W Yancy5, Sana M Al-Khatib1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27162231      PMCID： PMC4869988          DOI： 10.1161/CIRCHEARTFAILURE.116.003135

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN： 1941-3289            Impact factor:   8.790


× No keyword cloud information.
  4 in total

1.  Comparative Effectiveness of Implantable Cardioverter Defibrillators for Primary Prevention in Women.

Authors:  Emily P Zeitler; Anne S Hellkamp; Phillip J Schulte; Gregg C Fonarow; Adrian F Hernandez; Eric D Peterson; Gillian D Sanders; Clyde W Yancy; Sana M Al-Khatib
Journal:  Circ Heart Fail       Date:  2016-01       Impact factor: 8.790

2.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Authors:  Gust H Bardy; Kerry L Lee; Daniel B Mark; Jeanne E Poole; Douglas L Packer; Robin Boineau; Michael Domanski; Charles Troutman; Jill Anderson; George Johnson; Steven E McNulty; Nancy Clapp-Channing; Linda D Davidson-Ray; Elizabeth S Fraulo; Daniel P Fishbein; Richard M Luceri; John H Ip
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

3.  Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trials.

Authors:  Sana M Al-Khatib; Anne Hellkamp; Gust H Bardy; Stephen Hammill; W Jackson Hall; Daniel B Mark; Kevin J Anstrom; Jeptha Curtis; Hussein Al-Khalidi; Lesley H Curtis; Paul Heidenreich; Eric D Peterson; Gillian Sanders; Nancy Clapp-Channing; Kerry L Lee; Arthur J Moss
Journal:  JAMA       Date:  2013-01-02       Impact factor: 56.272

4.  Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention.

Authors:  Prateeti Khazanie; Anne S Hellkamp; Gregg C Fonarow; Deepak L Bhatt; Frederick A Masoudi; Kevin J Anstrom; Paul A Heidenreich; Clyde W Yancy; Lesley H Curtis; Adrian F Hernandez; Eric D Peterson; Sana M Al-Khatib
Journal:  J Am Heart Assoc       Date:  2015-08-06       Impact factor: 5.501
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.